Chris Sweeney, MBBS, director at the South Australian immunoGENomics Cancer Institute, joins The Uromigos to discuss 2022 highlights in GU oncology research as well as further research studies to be carried out in 2023, including the role of ADT with docetaxel for prostate cancer.